Biophysical Properties and Motility of Human Mature Dendritic Cells Deteriorated by Vascular Endothelial Growth Factor through Cytoskeleton Remodeling

Int J Mol Sci. 2016 Oct 31;17(11):1756. doi: 10.3390/ijms17111756.

Abstract

Dendritic cells (DCs), the most potent antigen-presenting cells, play a central role in the initiation, regulation, and maintenance of the immune responses. Vascular endothelial growth factor (VEGF) is one of the important cytokines in the tumor microenvironment (TME) and can inhibit the differentiation and functional maturation of DCs. To elucidate the potential mechanisms of DC dysfunction induced by VEGF, the effects of VEGF on the biophysical characteristics and motility of human mature DCs (mDCs) were investigated. The results showed that VEGF had a negative influence on the biophysical properties, including electrophoretic mobility, osmotic fragility, viscoelasticity, and transmigration. Further cytoskeleton structure analysis by confocal microscope and gene expression profile analyses by gene microarray and real-time PCR indicated that the abnormal remodeling of F-actin cytoskeleton may be the main reason for the deterioration of biophysical properties, motility, and stimulatory capability of VEGF-treated mDCs. This is significant for understanding the biological behavior of DCs and the immune escape mechanism of tumors. Simultaneously, the therapeutic efficacies may be improved by blocking the signaling pathway of VEGF in an appropriate manner before the deployment of DC-based vaccinations against tumors.

Keywords: biophysical characteristics; dendritic cells; immune function; motility; vascular endothelial growth factor.

MeSH terms

  • Actins / metabolism
  • Apoptosis / drug effects
  • Biophysical Phenomena / drug effects*
  • Cell Differentiation / drug effects*
  • Cell Movement / drug effects*
  • Cytoskeleton / drug effects
  • Cytoskeleton / metabolism*
  • Dendritic Cells / cytology*
  • Dendritic Cells / drug effects
  • Dendritic Cells / metabolism*
  • Down-Regulation / drug effects
  • Elasticity
  • Electrophoresis
  • Gene Expression Profiling
  • Gene Ontology
  • Human Umbilical Vein Endothelial Cells / drug effects
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Humans
  • Osmotic Fragility / drug effects
  • Pseudopodia / drug effects
  • Pseudopodia / metabolism
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Transendothelial and Transepithelial Migration / drug effects
  • Up-Regulation / drug effects
  • Vascular Endothelial Growth Factor A / pharmacology*
  • Viscosity

Substances

  • Actins
  • RNA, Messenger
  • Vascular Endothelial Growth Factor A